Evidence map›Paper›PMID 17634131›Full record

ArticleVirology journal2007

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.

Lachlan Gray, Melissa J Churchill, Jasminka Sterjovski, Kristie Witlox, Jennifer C Learmont, John S Sullivan, Steven L Wesselingh, Dana Gabuzda, Anthony L Cunningham, Dale A McPhee and 1 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Envelope gene evolution and HIV-1 neuropathogenesis.Journal of neuroinfectious diseases · 2015
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Lachlan GrayMacfarlane Burnet Institute for Medical Research and Public Health, Victoria, Australia. lachlang@burnet.edu.au
Melissa J Churchill
Jasminka Sterjovski
Kristie Witlox
Jennifer C Learmont
John S Sullivan
Steven L Wesselingh
Dana Gabuzda
Anthony L Cunningham
Dale A McPhee
Paul R Gorry
Burnet Institute · AUUniversity of Melbourne · AUAustralian Red Cross Lifeblood · AUDana-Farber Cancer Institute · USSt Vincents Institute of Medical Research · AUUniversity of Sydney · AUWestmead Institute · AU

Funding

CHEMOKINE RECEPTORS IN HIV1 INFECTION OF THE CNSR01NS037277 · NINDS · DANA-FARBER CANCER INSTITUTE · PI GABUZDA, DANA H. · 1998 to 2006
$2.9M
Pathogenesis of Macrophage Tropic HIV-1R21AI054207 · NIAID · MACFARLANE BURNET INST FOR RES/PUB HLTH · PI GORRY, PAUL R · 2003 to 2004
$324k
NIAID NIH HHS AI054207NIAID NIH HHS R21 AI054207NINDS NIH HHS NS37277NINDS NIH HHS R01 NS037277
6 · The paper itself

Abstract

backgroundThe Sydney blood bank cohort (SBBC) of long-term survivors consists of multiple individuals infected with attenuated, nef-deleted variants of human immunodeficiency virus type 1 (HIV-1) acquired from a single source. Long-term prospective studies have demonstrated that the SBBC now comprises slow progressors (SP) as well as long-term nonprogressors (LTNP). Convergent evolution of nef sequences in SBBC SP and LTNP indicates the in vivo pathogenicity of HIV-1 in SBBC members is dictated by factors other than nef. To better understand mechanisms underlying the pathogenicity of nef-deleted HIV-1, we examined the phenotype and env sequence diversity of sequentially isolated viruses (n = 2) from 3 SBBC members.

resultsThe viruses characterized here were isolated from two SP spanning a three or six year period during progressive HIV-1 infection (subjects D36 and C98, respectively) and from a LTNP spanning a two year period during asymptomatic, nonprogressive infection (subject C18). Both isolates from D36 were R5X4 phenotype and, compared to control HIV-1 strains, replicated to low levels in peripheral blood mononuclear cells (PBMC). In contrast, both isolates from C98 and C18 were CCR5-restricted. Both viruses isolated from C98 replicated to barely detectable levels in PBMC, whereas both viruses isolated from C18 replicated to low levels, similar to those isolated from D36. Analysis of env by V1V2 and V3 heteroduplex tracking assay, V1V2 length polymorphisms, sequencing and phylogenetic analysis showed distinct intra- and inter-patient env evolution.

conclusionIndependent evolution of env despite convergent evolution of nef may contribute to the in vivo pathogenicity of nef-deleted HIV-1 in SBBC members, which may not necessarily be associated with changes in replication capacity or viral coreceptor specificity.

Indexed as

HIV Long-Term SurvivorsAmino Acid SequenceBase SequenceGene Products, nefHIV-1HIV Envelope Protein gp120HIV InfectionsHumansMaleMolecular Sequence Datanef Gene Products, Human Immunodeficiency VirusPeptide FragmentsPhenotypePhylogenyPolymorphism, GeneticVirus ReplicationGene Products, nefHIV Envelope Protein gp120HIV envelope protein gp120 (135-148)HIV envelope protein gp120 (305-321)nef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1Peptide Fragments

Identifiers

PMID17634131
PMCPMC1939844
OpenAlexW2132366412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.